Predictive analysis of the situation of tuberculosis in the world based on the results of the annual WHO report
Background. A statistical analysis published in the WHO report for 2019 showed that almost 10.0 million people (about 9.0-11.1 million) fell ill with tuberculosis (TB) worldwide in 2018. The purpose of a systematic examination and analysis of the WHO report is to summarize the achievements and study of complex issues in overcoming tuberculosis in the world at the present stage, that need more attention, more scrutiny, or a change in approach to addressing specific challenges towards achieving the strategic global goals for eradicating this infection.
Materials and methods. We used test access to such full – text and abstract databases: a single package of the information database EBSCO; the largest abstract and citation database of peer-reviewed literature Scopus; Google Scholar; MEDLINE with Full Text; MEDLINE Complete; Dyna Med Plus; EBSCO eBooks Clinical Collection; Web of Science Core Collection WoS (CC); SCIE (Science Citation Index Expanded); SSCI (Social Science Citation Index); AHCI (Artand Humanities Citation Index).
Results and discussion. By geography, most TB cases in 2018 were reported in the WHO regions: Southeast Asia – 44 %, African – 24 % and Western Pacific – 18 %. Lower percentages were recorded in the Eastern Mediterranean (8 %), America (3 %) and Europe (3 %). Eight countries account for two – thirds of the world’s total TB cases: India (27 %), China (9 %), Indonesia (8 %), Philippines (6 %), Pakistan (6 %), Nigeria (4 %), Bangladesh (4 %) and South Africa (3 %). These and 22 other countries on the WHO list of 30 high tuberculosis countries account for 87 % of TB worldwide. Multidrugresistant tuberculosis (MDRTB) continues to be a public health threat worldwide. In 2018, about half a million new cases of rifampicin-resistant tuberculosis were reported (of which 78 % had multidrug-resistant tuberculosis). The three countries with the largest share of the global MRTB burden are India (27 %), China (14%) and the Russian Federation (9 %). Globally, 3.4 % of new cases of tuberculosis and 18% of previously treated cases are tuberculosis with extensively resistance or rifampicin-resistant (MDR/RR-TB), with the highest rates of detection (>50 % in previously detected cases) in the countries of the former Soviet Union.
Conclusion. The epidemic situation in TB in the world and Ukraine remains complex and at this stage has certain peculiarities, and the prognosis for its overcoming shortly is rather doubtful. There is a tendency to reduce the incidence of tuberculosis, but several complex and controversial issues have been outlined for the eradication of this infectious disease by WHO’s End TB strategy.
Feshchenko YuI, Todoriko LD, Kuzhko MM, Gumeniuk NI. Pathomorphosis of tuberculosis – the realities of the day and chemioresistance as a sign of it’s progression. Ukr Pulmonol J (Ukr). 2018; 2: 6-10. DOI: 10.31215/2306-4927-2018-100-2-6-10.
Accelerating progress on HIV, tuberculosis, malaria, hepatitis and neglected tropical diseases: A new agenda for 2016-2030. Geneva: World Health Organization; 2015 (https://www.who.int/about/structure/organigram/htm/progress-hiv-tb-malaria-ntd/en/, accessed 28 June 2019).
Assessing tuberculosis under-reporting through inventory studies. Geneva: World Health Organization; 2012 (https://www.who.int/tb/publications/inventory_studies/en/, accessed 8 August 2019).
Developing a draft TB multisectoral accountability framework. Background document. Stakeholder consultation convened by Global TB Programme, World Health Organization, Chateau de Penthes, Geneva, 1-2 March 2018. Geneva: World Health Organization; 2018 (https://www.who.int/tb/TBAccountabilityFramework_Consultation 1_2March_BackgroundDocument_20180228.pdf?ua=1, accessed 28 June 2019).
Developing a draft TB multisectoral accountability framework. Meeting report. Stakeholder consultation convened by Global TB Programme, World Health Organization, Chateau de Penthes, Geneva, 1-2 March 2018. Geneva: World Health Organization;2018 https://www.who.int/tb/TB_MAF_1_2Marchconsultation_meetingreport_ 20180322.pdf?ua=1, accessed 28 June 2019).
Dodd PJ, Gardiner E, Coghlan R, Seddon JA. Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. Lancet Glob Health. 2014; 2 (8): e453-9 (https://www.ncbi.nlm.nih.gov/pubmed/25103518, accessed 20 August 2019).
Dodd PJ, Yuen CM, Sismanidis C, Seddon JA, Jenkins HE. The global burden of tuberculosis mortality in children: a mathematical modelling study. Lancet Glob Health. 2017; 5 (9): e898–e906 (https://www.ncbi.nlm.nih.gov/pubmed/28807188, accessed 19 August 2019).
Draft Thirteenth General Programme of Work, 2019-2023. Geneva: World Health Organization; 2018 (http://apps.who.int/gb/ebwha/pdf_files/WHA71/A71_4-en.pdf?ua=1, accessed 1 August 2019).
Electronic recording and reporting for tuberculosis care and control. Geneva: World Health Organization; 2012. https://www.who.int/tb/publications/electronic_recording_ reporting /en/, accessed 25 July 2018).
Floyd K, Glaziou P, Houben R, Sumner T, White RG, Raviglione M. Global tuberculosis targets and milestones set for 2016-2035: definition and rationale. Int J Tuberc Lung Dis. 2018; 22 (7): 723-30 (https://www.ncbi.nlm.nih.gov/pubmed/29914597, accessed 8 August 2019).
GBD results tool [website]. Global Health Data Exchange; 2019 (http://ghdx. healthdata.org/gbd-results-tool, accessed June 2019).
Global health estimates 2016: disease burden by cause, age, sex, by country and by region, 2000-2016. Geneva: World Health Organization; 2018 (https://www.who.int/healthinfo/ global_burden_disease/estimates/en/index1.html, accessed 8 August 2019).
Global Task Force on TB Impact Measurement [website]. Geneva: World Health Organization; 2019 (https://www.who.int/tb/areas-of-work/monitoring-evaluation/impact_ measurement_taskforce/en/, accessed 22 July 2019).
Global tuberculosis report 2015 (WHO/HTM/TB/2015.22). Geneva: World Health Organization; 2015 (https://apps.who.int/iris/bitstream/handle/10665/191102/ 9789241565059_eng.pdf; jsessionid=257E179B-7641F5CE7FD14BEF18488436?sequence=1, accessed 28 June 2019).
Global tuberculosis report 2018. Geneva: World Health Organization; 2018 (https://apps.who.int/iris/handle/10665/274453, accessed 2 July 2019).
Hoa NB, Sy DN, Nhung NV, Tiemersma EW, Borgdorff MW, Cobelens FGJ. National survey of tuberculosis prevalence in Viet Nam. Bulletin of the World Health Organization. 2010; 88 (4): 273-80 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855599/, accessed 19 August 2019).
Horton KC, MacPherson P, Houben RM, White RG, Corbett EL. Sex differences in tuberculosis burden and notifications in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med. 2016; 13 (9): e1002119 (https://www.ncbi.nlm. nih.gov/pubmed/27598345, accessed 31 August 2019).
Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 2016; 13 (10): e1002152 (https://www.ncbi.nlm. nih.gov/pubmed/27780211, accessed 28 June 2019).
Implementing the End TB Strategy: the essentials (WHO/HTM/TB/2015.31). Geneva: World Health Organization; 2015 (https://www.who.int/tb/publications/2015/The_Essentials_to_End_TB/en/, accessed 28 June 2019).
International statistical classification of diseases and health related problems (The) ICD‑10. Geneva: World Health Organization; 2016 (https://icd.who.int/browse10/2016/en, accessed 8 August 2019).
Miotto P, Tessema B, Tagliani E, Chindelevitch L, Starks AM, Emerson C et al. A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis. Eur Respir J. 2017; 50 (6) (https://www.ncbi.nlm.nih.gov/pubmed/29284687, accessed 8 August 2019).
Moscow Declaration to End TB; First WHO global ministerial conference on ending TB in the sustainable development era: a multisectoral response. Geneva: World Health Organization and the Ministry of Health of the Russian Federation; 2017 (https://www.who.int/tb/features_archive/Moscow_Declaration_to_End_TB_ final_ENGLISH.pdf?ua=1, accessed 28 June 2019).
Multisectoral accountability framework to accelerate progress to end tuberculosis by 2030. Geneva: World Health Organization; 2019 (https://www.who.int/tb/WHO_Multisectoral_ Framework_web.pdf?ua=1, accessed 28 June 2019).
Popescu G, Dumitru M, Todoriko L, Lesnic E, Sorete-Arbore A, Pop CM, Semianiv I, Eremenchuk І. Comparative assessment of pulmonary tuberculosis cases from Chişinău, Iaşi county and Chernivtsi region. Pneumologia. 2017; 1: 36-41. (https://ibn.idsi.md/ro/vizualizare_articol/63912).
Preparation for a high-level meeting of the General Assembly on ending tuberculosis (WHA7.13), Seventy-first World Health Assembly. Geneva: World Health Organization; 2018 (http://apps.who.int/gb/ebwha/pdf_files/WHA71/A71_R3-en.pdf, accessed 11 July 2018).
Relational sequencing TB data platform [website]. Geneva: World Health Organization; 2019 (https://platform.reseqtb.org, accessed 8 August 2019).
Sanchez-Padilla E, Merker M, Beckert P, Jochims F, Dlamini T, Kahn P et al. Detection of drug-resistant tuberculosis by Xpert MTB/RIF in Swaziland. N Engl J Med. 2015; 372 (12): 1181-2 (https://www.ncbi.nlm.nih.gov/pubmed/25785984, accessed 15 August 2019).
Standards and benchmarks for tuberculosis surveillance and vital registration systems: checklist and user guide. Geneva: World Health Organization; 2014 (https://www.who.int/tb/publications/standardsandbenchmarks/en/, accessed 8 August 2019).
Shevchenko OS, Todoriko LD, Ovcharenko IA, Radzishevska YeB, Shvets OM, Ovcharenko SS, Semianiv IO, Vivsyannuk VV. Dynamics of aldosterone, parameters connective tissue reorganization and glucose level as markers for prognosis tuberculosis treatment effectiveness. Archives of the Balkan Medical Union. 2019 June; 54 (2): 274-280. DOI:10.31688/ABMU.2019.54.2.08.
Sustainable development goals [website]. New York: United Nations; (https://sustainabledevelopment.un.org/topics/sustainabledevelopmentgoals, accessed 28 June 2019).
TB fact sheet. Geneva: World Health Organization; 2019 (https://www.who.int/tb/publications/factsheet_tb_impactmeasurement.pdf?ua=1, accessed 22 July 2019).
The Global Plan to End TB, 2016-2020. Geneva: Stop TB Partnership; 2015 (http://www.stoptb.org/global/plan/, accessed 28 June 2019).
The use of next-generation sequencing technologies for the detection of mutations associated with drug resistance in Mycobacterium tuberculosis complex: technical guide. Geneva: World Health Organization; 2018 (https://apps.who.int/iris/bitstream/ handle/10665/274443/WHO-CDSTB‑2018.19-eng.pdf, accessed 17 July 2019).
Tuberculosis prevalence surveys: a handbook (WHO/HTM/TB/2010.17). Geneva: World Health Organization; 2011 https://www.who.int/tb/advisory_bodies/impact_measurement_ taskforce/resources_documents/thelimebook/en/, accessed 17 July 2019).
UNAIDS. AIDS info [website]. 2019 (http://aidsinfo.unaids.org/, accessed 15 August 2019).
United Nations General Assembly. Resolution 73/3: Political declaration of the high-level meeting of the General Assembly on the fight against tuberculosis. United Nations; 2018 (https://www.un.org/en/ga/search/view_doc.asp?symbol=A/RES/73/3, accessed 28 June 2019).
Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM et al. WHO’s new End TB strategy. Lancet. 2015; 385 (9979): 1799-801 (https://www.ncbi.nlm.nih.gov/ pubmed/25814376, accessed 28 June 2019).
WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2019 (https://www.who.int/tb/publications/2019/consolidated-guidelines-drug-resistant-TB-treatment/en/, accessed 17 July 2019).
World Health Organization Global Task Force on TB Impact Measurement. Third meeting of the TB estimates subgroup: methods to use for WHO’s definitive assessment of whether 2015 global TB targets are met. Geneva: World Health Organization; 2015 (https://www.who.int/tb/advisory_bodies/impact_measurement_taskforce/ meetings/consultation_april_2015_tb_estimates_subgroup/en/, accessed 8 August 2018).
World Health Organization Global Task Force on TB Impact Measurement. Report of the sixth meeting of the full Task Force; 19-21 April 2016, Glion-sur-Montreux, Switzerland. Geneva: World Health Organization; 2016 (https://www.who.int/tb/advisory_bodies/ impact_measurement_taskforce/meetings/tf6_report.pdf?ua=1, accessed 8 August 2019).
World Health Organization Strategic and Technical Advisory Group for TB. Use of high burden country lists for TB by WHO in the post‑2015 era (discussion paper). Geneva: World Health Organization; 2015 (https://www.who.int/tb/publications/global_report/high_tb_ burdencountrylists2016-2020.pdf, accessed 28 June 2019).
World Health Organization/World Bank. Tracking universal health coverage: 2017 global monitoring report. Geneva: World Health Organization; 2017 (https://apps.who.int/iris/ bitstream/handle/10665/259817/9789241513555-eng.pdf, accessed 28 June 2019).
World Health Organization/World Bank. Tracking universal health coverage: first global monitoring report. Geneva: World Health Organization; 2015 (https://apps.who.int/iris/bitstream/handle/10665/174536/9789241564977_ eng.pdf?sequence=1, accessed 28 June 2019).
Zignol M, Cabibbe AM, Dean AS, Glaziou P, Alikhanova N, Ama C et al. Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study. Lancet Infect Dis. 2018; 18 (6): 675-83 (https://www.ncbi.nlm.nih.gov/pubmed/29574065, accessed 8 August 2019).
Zignol M, Dean AS, Alikhanova N, Andres S, Cabibbe AM, Cirillo DM et al. Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project. Lancet Infect Dis. 2016; 16: 30190-6 (https://www.ncbi.nlm.nih.gov/pubmed/27397590, accessed 8 August 2019).
This work is licensed under a Creative Commons Attribution 4.0 International License.